BIB ProShares Ultra Nasdaq Biotechnology
NASDAQ Biotechnology TR USD

NAV as of 13-May-2022

45.2842

4 Week: 40.21 - 61.13

52 Week: 40.21 - 110.40

Latest Closing Price

45.88

Premium / Discount

0.04

Expense Ratio

0.95%

Investment Objective

The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.

Main Fund Characteristics

Fund Manager:
ProShares
Asset Under Management:
202,287,421
Launch Date:
05/04/2010
Asset Class:
Miscellaneous
Replication Method:
Derivative Based
Number of Holdings:
378
Trading Currency:
USD
Style:
Mid Blend
Region/Sector/Strategy:
N.A / N.A / Equity
Exchange:
NASDAQ

Performance

Period Performance Returns(%) Volatility(%) Risk Adjusted Performance
YTD-40.193.88-10.37
1 Day5.750.000.00
1 Week12.3412.401.00
1 Month-23.6123.22-1.02
3 Months-16.3431.83-0.51
6 Months-42.9540.60-1.06
1 Year-41.4048.98-0.85
2 Years-29.0268.90-0.42
3 Years2.7793.310.03
5 Years4.34111.940.04
10 Years3.21188.120.02

Price History

-

Annual Performance Return

2012201320142015201620172018201920202021
Price (%) 67.1237160.138266.697613.7964-44.225140.7379-24.362445.504639.7412-5.9111
Nav (%) 0.00000.00000.00000.00000.00000.00000.00000.00000.00000.0000
Rank 0.00000.00000.00000.00000.00000.00000.00000.00000.00000.0000

Dividend Frequency

Lastest Dividend

Ex Date Payment Date Dividend Payout per unit
20/09/201027/09/20100.0439

Portfolio Data

Total Number of Holdings: 378

Number of Bond Holdings: 0

Number of Equity Holdings: 377

Total Market Value: 202,287,421

Portfolio Composition

Top 10 Holdings

% Portfolio Weight Shares Owned Shares Changed Market Value
1Nasdaq Biotechnology Index Swap Goldman Sachs Inte25.44616,763025,433,208
2Nasdaq Biotechnology Index Swap Societe Generale25.16776,689025,154,921
3Nasdaq Biotechnology Index Swap Citibank Na23.88476,348-12223,872,543
4Nasdaq Biotechnology Index Swap Ubs Ag12.83783,412012,831,304
5Nasdaq Biotechnology Index Swap Bank Of America Na11.26892,995-5,89511,263,117

Country Exposure

Regional Exposure

America

Greater Europe

Greater Asia

Market Classification

Market Capitalization

Size% of portfolio
Giant8.14
Large31.74
Medium25.47
Small20.13
Micro3.82

Equity Style Box Breakdown

000Large
000Mid
000Small
ValueBlendGrowth

Value Measures

Price/Prospective Earnings*

12.0167

Price/Book*

2.8100

Price/Sales*

1.9141

Price/Cash Flow*

9.6738

Dividend Yield*

0.9843

Growth Measures

Long-Term Earnings

12.3539

Historical Earnings

17.1508

Sales Growth

11.7130

Cash-Flow Growth

12.9480

Book-Value Growth

6.7829

*Forward-looking based on historical data.

Equity Sector

Number of Bond Holdings

0

Bond Statitics

DetailValue
Average Effective Duration0
Average Effective Maturity (Years)*0
Average Credit Quality0
Average Weighted Coupon*0
Average Weighted Price*0

Bond Style Box Breakdown

000HighQuality
000Med
000Low
LtdModExt
Interest-Rate Sensitivity

Credit Quality

Type% Bonds
N.A

Bond Sector

Type
% Bonds

Bond Maturity

% Bonds
N.A

Data Source: Morningstar

© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:

(1) include the proprietary information of Morningstar and Morningstar’s third party licensors;
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.

Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.